Emergence of the Asian lineage of Zika virus in Angola: an outbreak investigation.


Journal

The Lancet. Infectious diseases
ISSN: 1474-4457
Titre abrégé: Lancet Infect Dis
Pays: United States
ID NLM: 101130150

Informations de publication

Date de publication:
10 2019
Historique:
received: 25 01 2019
revised: 05 05 2019
accepted: 30 05 2019
entrez: 28 9 2019
pubmed: 29 9 2019
medline: 11 6 2020
Statut: ppublish

Résumé

Zika virus infections and suspected microcephaly cases have been reported in Angola since late 2016, but no data are available about the origins, epidemiology, and diversity of the virus. We aimed to investigate the emergence and circulation of Zika virus in Angola. Diagnostic samples collected by the Angolan Ministry of Health as part of routine arboviral surveillance were tested by real-time reverse transcription PCR by the Instituto Nacional de Investigação em Saúde (Ministry of Health, Luanda, Angola). To identify further samples positive for Zika virus and appropriate for genomic sequencing, we also tested samples from a 2017 study of people with HIV in Luanda. Portable sequencing was used to generate Angolan Zika virus genome sequences from three people positive for Zika virus infection by real-time reverse transcription PCR, including one neonate with microcephaly. Genetic and mobility data were analysed to investigate the date of introduction and geographical origin of Zika virus in Angola. Brain CT and MRI, and serological assays were done on a child with microcephaly to confirm microcephaly and assess previous Zika virus infection. Serum samples from 54 people with suspected acute Zika virus infection, 76 infants with suspected microcephaly, 24 mothers of infants with suspected microcephaly, 336 patients with suspected dengue virus or chikungunya virus infection, and 349 samples from the HIV study were tested by real-time reverse transcription PCR. Four cases identified between December, 2016, and June, 2017, tested positive for Zika virus. Analyses of viral genomic and human mobility data suggest that Zika virus was probably introduced to Angola from Brazil between July, 2015, and June, 2016. This introduction probably initiated local circulation of Zika virus in Angola that continued until at least June, 2017. The infant with microcephaly in whom CT and MRI were done had brain abnormalities consistent with congenital Zika syndrome and serological evidence for Zika virus infection. Our analyses show that autochthonous transmission of the Asian lineage of Zika virus has taken place in Africa. Zika virus surveillance and surveillance of associated cases of microcephaly throughout the continent is crucial. Royal Society, Wellcome Trust, Global Challenges Research Fund (UK Research and Innovation), Africa Oxford, John Fell Fund, Oxford Martin School, European Research Council, Departamento de Ciência e Tecnologia/Ministério da Saúde/National Council for Scientific and Technological Development, and Ministério da Educação/Coordenação de Aperfeicoamento de Pessoal de Nível Superior.

Sections du résumé

BACKGROUND
Zika virus infections and suspected microcephaly cases have been reported in Angola since late 2016, but no data are available about the origins, epidemiology, and diversity of the virus. We aimed to investigate the emergence and circulation of Zika virus in Angola.
METHODS
Diagnostic samples collected by the Angolan Ministry of Health as part of routine arboviral surveillance were tested by real-time reverse transcription PCR by the Instituto Nacional de Investigação em Saúde (Ministry of Health, Luanda, Angola). To identify further samples positive for Zika virus and appropriate for genomic sequencing, we also tested samples from a 2017 study of people with HIV in Luanda. Portable sequencing was used to generate Angolan Zika virus genome sequences from three people positive for Zika virus infection by real-time reverse transcription PCR, including one neonate with microcephaly. Genetic and mobility data were analysed to investigate the date of introduction and geographical origin of Zika virus in Angola. Brain CT and MRI, and serological assays were done on a child with microcephaly to confirm microcephaly and assess previous Zika virus infection.
FINDINGS
Serum samples from 54 people with suspected acute Zika virus infection, 76 infants with suspected microcephaly, 24 mothers of infants with suspected microcephaly, 336 patients with suspected dengue virus or chikungunya virus infection, and 349 samples from the HIV study were tested by real-time reverse transcription PCR. Four cases identified between December, 2016, and June, 2017, tested positive for Zika virus. Analyses of viral genomic and human mobility data suggest that Zika virus was probably introduced to Angola from Brazil between July, 2015, and June, 2016. This introduction probably initiated local circulation of Zika virus in Angola that continued until at least June, 2017. The infant with microcephaly in whom CT and MRI were done had brain abnormalities consistent with congenital Zika syndrome and serological evidence for Zika virus infection.
INTERPRETATION
Our analyses show that autochthonous transmission of the Asian lineage of Zika virus has taken place in Africa. Zika virus surveillance and surveillance of associated cases of microcephaly throughout the continent is crucial.
FUNDING
Royal Society, Wellcome Trust, Global Challenges Research Fund (UK Research and Innovation), Africa Oxford, John Fell Fund, Oxford Martin School, European Research Council, Departamento de Ciência e Tecnologia/Ministério da Saúde/National Council for Scientific and Technological Development, and Ministério da Educação/Coordenação de Aperfeicoamento de Pessoal de Nível Superior.

Identifiants

pubmed: 31559967
pii: S1473-3099(19)30293-2
doi: 10.1016/S1473-3099(19)30293-2
pmc: PMC6892302
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1138-1147

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Références

Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
Nat Commun. 2018 Apr 11;9(1):1391
pubmed: 29643334
Cell Host Microbe. 2018 Jun 13;23(6):855-864.e7
pubmed: 29805095
PLoS Curr. 2018 Mar 15;10:null
pubmed: 29637009
Lancet. 2017 Apr 22;389(10079):1595-1596
pubmed: 28593839
BMJ Glob Health. 2016 Aug 1;1(2):e000087
pubmed: 28588942
JAMA Neurol. 2016 Dec 1;73(12):1407-1416
pubmed: 27695855
Science. 2016 Apr 15;352(6283):345-349
pubmed: 27013429
Cell. 2018 Mar 8;172(6):1160-1162
pubmed: 29522736
MMWR Morb Mortal Wkly Rep. 2016 Jun 03;65(21):543-6
pubmed: 27254248
PLoS Negl Trop Dis. 2014 Jan 09;8(1):e2636
pubmed: 24421913
Nature. 2017 Jun 15;546(7658):406-410
pubmed: 28538727
Nat Protoc. 2017 Jun;12(6):1261-1276
pubmed: 28538739
BMC Med. 2015 Apr 30;13:102
pubmed: 25976325
Lancet. 2017 Nov 4;390(10107):2099-2109
pubmed: 28647173
Nat Microbiol. 2019 Jan;4(1):10-19
pubmed: 30546099
Front Immunol. 2014 Sep 16;5:446
pubmed: 25278941
Lancet Infect Dis. 2018 Mar;18(3):328-336
pubmed: 29242091
Trans R Soc Trop Med Hyg. 2018 Oct 1;112(10):458-462
pubmed: 30053235
Emerg Infect Dis. 2019 Apr;25(4):784-787
pubmed: 30882320
MMWR Morb Mortal Wkly Rep. 2013 Jun 21;62(24):504-7
pubmed: 23784016
Clin Infect Dis. 2018 Apr 3;66(8):1173-1180
pubmed: 29300893
Lancet Infect Dis. 2016 Nov;16(11):1237-1245
pubmed: 27593584
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638

Auteurs

Sarah C Hill (SC)

Department of Zoology, University of Oxford, Oxford, UK.

Jocelyne Vasconcelos (J)

Instituto Nacional de Investigação em Saúde, Ministry of Health, Luanda, Angola.

Zoraima Neto (Z)

Instituto Nacional de Investigação em Saúde, Ministry of Health, Luanda, Angola.

Domingos Jandondo (D)

Instituto Nacional de Investigação em Saúde, Ministry of Health, Luanda, Angola.

Líbia Zé-Zé (L)

Instituto Nacional de Saúde Doutor Ricardo Jorge, Águas de Moura, Portugal; University of Lisboa, Faculty of Sciences, BioISI-Biosystems & Integrative Sciences Institute, Lisbon, Portugal.

Renato Santana Aguiar (RS)

Departamento de Genética, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Joilson Xavier (J)

Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Julien Thézé (J)

Department of Zoology, University of Oxford, Oxford, UK.

Marinela Mirandela (M)

Instituto Nacional de Investigação em Saúde, Ministry of Health, Luanda, Angola.

Ana Luísa Micolo Cândido (AL)

Instituto Nacional de Investigação em Saúde, Ministry of Health, Luanda, Angola.

Filipa Vaz (F)

Instituto Nacional de Investigação em Saúde, Ministry of Health, Luanda, Angola.

Cruz Dos Santos Sebastião (CDS)

Instituto Nacional de Investigação em Saúde, Ministry of Health, Luanda, Angola; Instituto Superior de Ciências da Saúde, Universidade Agostinho Neto, Luanda, Angola.

Chieh-Hsi Wu (CH)

Department of Statistics, University of Oxford, Oxford, UK.

Moritz U G Kraemer (MUG)

Department of Zoology, University of Oxford, Oxford, UK; Computational Epidemiology Lab, Boston Children's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

Adriana Melo (A)

Instituto de Pesquisa Professor Joaquim Amorim Neto, Campina Grande, Brazil.

Bruno L F Schamber-Reis (BLF)

Department of Human Genetics, Centro Universitário Unifacisa, Campina Grande, Brazil.

Girlene S de Azevedo (GS)

Instituto de Pesquisa Professor Joaquim Amorim Neto, Campina Grande, Brazil.

Amilcar Tanuri (A)

Departamento de Genética, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Luiza M Higa (LM)

Departamento de Genética, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Carina Clemente (C)

Cligest Clinic, Luanda, Angola.

Sara Pereira da Silva (SP)

Cligest Clinic, Luanda, Angola.

Darlan da Silva Candido (D)

Department of Zoology, University of Oxford, Oxford, UK.

Ingra M Claro (IM)

Instituto de Medicina Tropical e Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Domingos Quibuco (D)

Hospital Pediátrico David Bernardino, Luanda, Angola.

Cristóvão Domingos (C)

Instituto Nacional de Luta Contra SIDA, Luanda, Angola.

Bárbara Pocongo (B)

Instituto Nacional de Luta Contra SIDA, Luanda, Angola.

Alexander G Watts (AG)

Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada; BlueDot, Toronto, ON, Canada.

Kamran Khan (K)

Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada; BlueDot, Toronto, ON, Canada; Department of Medicine, University of Toronto, Canada.

Luiz Carlos Junior Alcantara (LCJ)

Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; Laboratório de Flavivirus, IOC-Fundação Oswaldo Cruz/MS, Rio de Janeiro, Brazil.

Ester C Sabino (EC)

Instituto de Medicina Tropical e Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Eve Lackritz (E)

WHO, Switzerland, Geneva.

Oliver G Pybus (OG)

Department of Zoology, University of Oxford, Oxford, UK.

Maria-João Alves (MJ)

Instituto Nacional de Saúde Doutor Ricardo Jorge, Águas de Moura, Portugal.

Joana Afonso (J)

Instituto Nacional de Investigação em Saúde, Ministry of Health, Luanda, Angola. Electronic address: jfm.morais9@gmail.com.

Nuno R Faria (NR)

Department of Zoology, University of Oxford, Oxford, UK. Electronic address: nuno.faria@zoo.ox.ac.uk.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH